Effect of Vitamin D3 Supplementation on Brain Waves in Male Parkinson's Disease Patients With Hypovitaminosis D : A Quantitative Electroencephalogram Analysis

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is an experimental study (Interventional self-controlled trial, pretest-posttest design). The goal of this clinical trial is to evaluate the effect of vitamin D3 supplementation on quantitative EEG in male Parkinson's disease patients with hypovitaminosis D. The main question it aims to answer is: Vitamin D3 supplementation has effect on brain waves in male Parkinson's disease patients with hypovitaminosis D. Researcher will compare the effect of vitamin D3 supplementation on brain waves in male Parkinson's disease patients with hypovitaminosis D with their pre intervention ( baseline ) condition on brain waves to assess whether there will be any improvement of brain electrical activity by quantitative electroencephalogram (QEEG). Participants will : Take vitamin D3 orally for 8 weeks (50,000 IU/week) Visit the medical university after 8 weeks for evaluation of serum 25(OH)D level and QEEG Must bring the empty strips of vitamin D supplement with them during their visit.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 51
Maximum Age: 70
Healthy Volunteers: f
View:

• Male Patients with PD up to stage 3 according to Hoehn and Yahr (H-Y) scale

• Age: 51years to70 years

• BMI: 18.5-24.9 kg/m2

• Hypovitaminosis D (Serum 25(OH)D level \<30 ng/ml)

• Patients on Levodopa therapy

Locations
Other Locations
Bangladesh
Bangladesh medical university
RECRUITING
Dhaka
Time Frame
Start Date: 2025-07-15
Estimated Completion Date: 2025-11
Participants
Target number of participants: 15
Treatments
Experimental: Male Parkinson's disease patients with hypovitaminosis D
15 Male Parkinson's disease patients with hypovitaminosis D will be supplemented with vitamin D orally 50,000 IU/week for 8 weeks
Related Therapeutic Areas
Sponsors
Leads: Bangladesh Medical University

This content was sourced from clinicaltrials.gov